These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 1736014

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Risk assessment in primary myelodysplastic syndromes: validation of the Düsseldorf score.
    Aul C, Gattermann N, Germing U, Runde V, Heyll A, Schneider W.
    Leukemia; 1994 Nov; 8(11):1906-13. PubMed ID: 7967735
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Circulating myeloid colony-forming cells predict survival in myelodysplastic syndromes.
    Berer A, Jäger E, Sagaster V, Streubel B, Wimazal F, Sperr WR, Welterman A, Schwarzinger I, Frommlet F, Haas OA, Valent P, Lechner K, Geissler K, Ohler L.
    Ann Hematol; 2003 May; 82(5):271-7. PubMed ID: 12739063
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: Results of a single-center analysis.
    Müller-Berndorff H, Haas PS, Kunzmann R, Schulte-Mönting J, Lübbert M.
    Ann Hematol; 2006 Aug; 85(8):502-13. PubMed ID: 16715299
    [Abstract] [Full Text] [Related]

  • 9. Myelodysplastic syndromes in patients under 50 years old: a single institution experience.
    Breccia M, Mengarelli A, Mancini M, Biondo F, Gentilini F, Latagliata R, Mandelli F, Alimena G.
    Leuk Res; 2005 Jul; 29(7):749-54. PubMed ID: 15927670
    [Abstract] [Full Text] [Related]

  • 10. Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients.
    Navarro I, Ruiz MA, Cabello A, Collado R, Ferrer R, Hueso J, Martinez J, Miguel A, Orero MT, Pérez P, Nolasco A, Carbonell F.
    Leuk Res; 2006 Aug; 30(8):971-7. PubMed ID: 16423393
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Prediction of survival in myelodysplastic syndrome. Analysis of 2 scoring systems with prognostic value].
    Sanz GF, Sanz MA, Vallespí T, Cañizo MC, García S, Torrabadella M, San Miguel JF, Irriguible D.
    Sangre (Barc); 1989 Feb; 34(1):41-6. PubMed ID: 2711284
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan.
    Toyama K, Ohyashiki K, Yoshida Y, Abe T, Asano S, Hirai H, Hirashima K, Hotta T, Kuramoto A, Kuriya S.
    Leukemia; 1993 Apr; 7(4):499-508. PubMed ID: 8464227
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.